Grufity logoGrufity logo

NVTA

2.61USD-0.17(-6.12%)Market Closed

Invitae Corp

Market Summary

USD2.61-0.17Market Closed
-6.12%

NVTA Alerts

NVTA Stock Price

RSI Chart

Valuation

Market Cap

555.2M

Price/Earnings

-0.18

Price/Sales

1.11

Price/Cashflow

-0.89

MarketCap/EBT

-0.18

Price/Sales

Profitability

Operating Margin

21.87%

EBT Margin

-631.07%

Return on Equity

-805.54%

Return on Assets

-135.72%

Fundamentals

Revenue

Revenue (TTM)

520.0M

Revenue Y/Y

16.73%

Revenue Q/Q

-2.26%

Earnings

Earnings (TTM)

-3.2B

Earnings Y/Y

-51.96%

Earnings Q/Q

88.07%

Price Action

52 Week Range

1.8318.44
(Low)(High)

Last 7 days

-4.7%

Last 30 days

10.6%

Last 90 days

-11.8%

Trailing 12 Months

-85.5%

Financial Health

Current Ratio

6.42

Investor Care

Shares Dilution (1Y)

7.30%

Diluted EPS (TTM)

-13.89

Peers (Alternatives to Invitae)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
261.0B
57.8B
7.33% 41.28%
20.65
4.55
4.80% 77.95%
81.0B
14.2B
-1.24% 15.25%
14.24
5.69
14.88% -8.36%
80.6B
8.7B
0.45% 71.74%
24.61
9.26
22.03% 50.41%
16.6B
3.3B
4.33% 13.82%
17.56
5
22.05% 63.88%
MID-CAP
4.6B
776.0M
-21.30% -60.37%
-8.03
6.39
37.38% -33.90%
3.8B
249.9M
-21.94% -61.12%
-24.67
15.19
132.20% -22.25%
SMALL-CAP
1.4B
268.4M
30.86% -39.20%
-28.41
5.15
70.42% 22.87%
1.1B
314.9M
-37.46% -70.76%
-15.26
3.36
24.16% -675.60%
616.1M
123.7M
-12.04% -52.20%
-13.85
5.59
43.31% -77.98%
555.2M
520.0M
10.59% -85.49%
-0.18
1.11
19.60% -686.73%
431.9M
463.2M
-20.00% -73.47%
5.91
0.94
3.79% -0.40%
153.0M
-
-9.38% -39.19%
-4.99
-
- -39.92%
9.1M
3.3M
-9.56% -89.22%
-0.36
2.22
-21.77% 4.40%

Financials for Invitae

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue3.8%520501481460435
  S&GA Expenses-2.6%234241235226213
  R&D Expenses-2.2%462473464416356
Earnings Before Taxes-3.1%-3,258.80-3,160.60-516.35-415.86-546.93
Net Income-3.3%-3,211.60-3,108.62-451.37-379.01-408.22
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-11.5%2,0262,2914,7684,9205,071
  Current Assets-18.4%7308941,0311,1791,366
    Cash Equivalents-28.5%217304325923922
  Inventory-39.1%3049433431
  Net PPE-14.3%114133130115101
  GoodwillNaN%--2,2832,2832,283
Liabilities-2.0%1,8671,9051,9241,9411,964
  Current Liabilities-18.6%113139168144156
Shareholder's Equity-58.8%1593862,8442,9783,107
  Retained Earnings-6.8%-4,729.32-4,428.17-1,904.71-1,722.85-1,517.72
  Additional Paid-In Capital1.5%4,8894,8154,7494,7014,624
Accumulated Depreciation25.5%7560544845
Shares Outstanding1.6%232228228218-
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations5.8%-586.85-623.20-617.84-559.82-497.48
  Share Based Compensation19.7%213178168180188
Cashflow From Investing33.7%-126.19-190.31-379.98-204.08-686.87
Cashflow From Financing-10.5%891,1291,5662,003

Risks

What is the probability of a big loss on NVTA?

100%


Probability that Invitae stock will be more than 20% underwater in next one year

98.8%


Probability that Invitae stock will be more than 30% underwater in next one year.

84.2%


Probability that Invitae stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does NVTA drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Invitae was unfortunately bought at previous high price.

Returns

Cumulative Returns on NVTA

-14.3%


7-Year Cumulative Returns

-21.1%


5-Year Cumulative Returns

-49.2%


3-Year Cumulative Returns

What are the long-term rolling returns for NVTA?

FIve years rolling returns for Invitae.

Which funds bought or sold NVTA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-22
Capital Impact Advisors, LLC
REDUCED
-39.91
-50,000
140,000
0.14%
2022-11-22
IHT Wealth Management, LLC
ADDED
4.98
5,000
94,000
0.01%
2022-11-22
Seaport Global Advisors, LLC
REDUCED
-43.64
-58,000
77,000
0.31%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
REDUCED
-3.61
-20,000
690,000
-%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
ADDED
452.72
33,000
40,000
-%
2022-11-15
JANE STREET GROUP, LLC
REDUCED
-50.46
-179,000
178,000
-%
2022-11-15
MERCER GLOBAL ADVISORS INC /ADV
ADDED
1.47
1,000
53,000
-%
2022-11-15
CreativeOne Wealth, LLC
ADDED
27
53,000
243,000
0.01%
2022-11-15
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO
UNCHANGED
-
-
65,000
-%
2022-11-15
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
SOLD OFF
-
-
-
-%

1–10 of 40

Latest Funds Activity

Are funds buying NVTA calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own NVTA

Invitae News

InvestorsObserver

Invitae Corp (NVTA) Stock Is Down -8.00% This Week: Buy, Hold, or Sell?.3 days ago

The Motley Fool

NVTA Fair Value

Recent SEC filings of Invitae

View All Filings
Date Filed Form Type Document
Nov 09, 2022
8-K/A
Current Report
Nov 08, 2022
8-K
Current Report
Nov 08, 2022
10-Q
Quarterly Report
Aug 29, 2022
4
Insider Trading
Aug 25, 2022
8-K
Current Report
Aug 24, 2022
4
Insider Trading
Aug 24, 2022
4
Insider Trading
Aug 24, 2022
4
Insider Trading
Aug 24, 2022
4
Insider Trading

Latest Insider Trading transactions for NVTA

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-08-25
WERNER ROBERT F.
SOLD
-4,657.5
3.45
-1,350
Chief Accounting Officer
2022-08-22
WERNER ROBERT F.
ACQUIRED
-
-
54,000
Chief Accounting Officer
2022-08-22
Nussbaum Robert L
ACQUIRED
-
-
54,000
Chief Medical Officer
2022-08-22
Wen Yafei
ACQUIRED
-
-
102,000
Chief Financial Officer
2022-08-22
Brida Thomas
ACQUIRED
-
-
54,000
See Remarks
2022-08-16
George Sean E
SOLD
-100,493
4.5503
-22,085
-
2022-08-16
Nussbaum Robert L
SOLD
-32,070.5
4.5503
-7,048
Chief Medical Officer
2022-08-16
Brida Thomas
SOLD
-32,070.5
4.5503
-7,048
See remarks
2022-08-16
WERNER ROBERT F.
SOLD
-14,797.6
4.5503
-3,252
Chief Accounting Officer
2022-07-17
George Sean E
ACQUIRED
-
-
16,050
-

1–10 of 50

Sean E. George
3000
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

NVTA Income Statement

2022-09-30
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue:    
Total revenue$ 133,536$ 114,395$ 393,849$ 334,328
Cost of revenue116,95687,741324,412252,563
Research and development87,17797,511330,559284,323
Selling and marketing49,19355,501172,086163,705
General and administrative44,93986,820149,071197,640
Asset impairments6,70802,324,5720
Change in fair value of contingent consideration0(19,866)(1,850)(386,836)
Restructuring118,5140118,5140
Total cost and operating expenses423,487307,7073,417,364511,395
Loss from operations(289,951)(193,312)(3,023,515)(177,067)
Other income, net1,8723,35719,6379,846
Interest expense(14,145)(14,069)(42,149)(35,869)
Net loss before taxes(302,224)(204,024)(3,046,027)(203,090)
Income tax benefit(1,068)(5,848)(39,551)(29,208)
Net loss$ (301,156)$ (198,176)$ (3,006,476)$ (173,882)
Net (loss) income per share, basic (in dollars per share)$ (1.27)$ (0.91)$ (12.91)$ (0.85)
Net (loss) income per share, diluted (in dollars per share)$ (1.27)$ (0.91)$ (12.91)$ (0.85)
Shares used in computing net loss per share, basic237,974218,384232,889205,587
Shares used in computing net loss per share, diluted237,974218,384232,889205,587
Test revenue    
Revenue:    
Total revenue$ 128,839$ 111,676$ 381,518$ 322,448
Other revenue    
Revenue:    
Total revenue$ 4,697$ 2,719$ 12,331$ 11,880

NVTA Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 217,029$ 923,250
Marketable securities368,936122,121
Accounts receivable89,13066,227
Inventory29,90233,516
Prepaid expenses and other current assets24,67933,691
Total current assets729,6761,178,805
Property and equipment, net113,878114,714
Operating lease assets109,971121,169
Restricted cash10,02710,275
Intangible assets, net1,041,1851,187,994
Goodwill02,283,059
Other assets21,51823,551
Total assets2,026,2554,919,567
Current liabilities:  
Accounts payable10,72721,127
Accrued liabilities83,116106,453
Operating lease obligations14,19912,359
Finance lease obligations5,2794,156
Total current liabilities113,321144,095
Operating lease obligations, net of current portion138,167124,369
Finance lease obligations, net of current portion4,8485,683
Debt120,097113,391
Convertible senior notes, net1,469,1081,464,138
Deferred tax liability9,18151,696
Other long-term liabilities12,66737,797
Total liabilities1,867,3891,941,169
Commitments and contingencies
Stockholders’ equity:  
Common stock2423
Accumulated other comprehensive loss(898)(7)
Additional paid-in capital4,889,0644,701,230
Accumulated deficit(4,729,324)(1,722,848)
Total stockholders’ equity158,8662,978,398
Total liabilities and stockholders’ equity$ 2,026,255$ 4,919,567